Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Do you ever treat regional lymph nodes for malignant phyllodes tumor of the breast?
In what situations would you want to include regional nodes? Particular tumor size?
Answer from: Radiation Oncologist at Community Practice
I have not treated regional nodes in malignant phyllodes cases, even in larger tumors.
Sign in or Register to read more
10764
Related Questions
Does the presence of LCIS on pathology in a patient with IDC impact your decision to offer APBI?
What is your preferred sequencing of adjuvant chemotherapy and PMRT for node + breast cancer?
How do you approach boost to the lumpectomy cavity AND 4 lymph nodes with extra-nodal extension when treating breast cancer with hypofractionation?
If a patient has multiple PET-avid level 3, supraclavicular, or IMN nodes that are small and would have been considered negative by size criteria with traditional imaging, that are no longer positive on PET after chemotherapy, would you try to boost these nodes?
With the presentation of HypoG-01 phase III UNICANCER trial at ESMO 2024, should hypofractionated radiotherapy be the standard across the board for breast cancer?
Under what circumstances would you pursue completion ALND in a patient with multiple positive sentinel nodes after breast-conserving surgery?
What are your top takeaways in Radiation Oncology from SABCS 2024?
Have the breast surgeons at your institution adopted the SOUND trial into their clinical practice?
Does micropapillary subtype for a G1-2 DCIS affect your radiation treatment recommendations?
In cT4aN0 triple negative breast cancer would you still recommend PMRT if pCR, ypT0N0(sn), after neoadj chemo is achieved?